Adverse drug reactions - basic principles
Any drug that is capable of producing beneficial therapeutic effects can also cause unwanted ‘adverse’ effects. Adverse drug reactions (ADRs) are therefore common and constitute an important public health challenge in their own right. A significant proportion of admissions to hospital are caused by ADRs and hospitalised patients frequently experience ADRs that complicate and prolong their stay. Many of these ADRs can be avoided if greater care is taken. All prescribers need to make a judgment about the likelihood that a patient will either gain from the beneficial effects or experience an ADR before prescribing. Some drugs rarely cause ADRs (e.g. paracetamol) while others frequently do so (e.g. cancer chemotherapy). The decision to prescribe these ‘higher risk’ drugs will depend on the extent of the potential benefits. Although prescribers always face the possibility of causing an ADR the risks of doing so can be minimised by (i) recognition of patient and drug factors that increase the susceptibility and (ii) by counselling patients about early indications that an ADR may be developing.
Understanding adverse drug reactions and drug allergies: principles, diagnosis and treatment aspects.
Yellow Card Centre Scotland- Basic principles of adverse drug reactions
This is one of a set of webpages containing key information relevant to understanding the importance of ADRs in modern healthcare. This module contains an introduction, outlines how ADRs are defined in the EU, and includes a case study to test the outcome of your learning process. Suitable for intermediate level learners. These learning resources were developed by the Yellow Card Centre (YCC) Scotland in conjunction with NHS Education for Scotland (NES).
WHO Medication Safety Curriculum Guide 2019
The Medication Safety Curriculum Guide was produced to support implementation of the Third WHO Global Patient Safety Challenge: Medication Without Harm, that was launched in 2017. It provides an overview of those aspects of medication safety that should be taught to undergraduate and postgraduate health care students and practicing health professionals, their educators, and relevant professional bodies.
This 22-page open-access article published by Zahra Pourpak et al. in the Journal Recent Patents on Inflammation & Allergy Drug Discovery, describes in detail the WHO definition of adverse drug reactions (ADRs), the common features, classification according to Rawlins and Thompson and beyond. The authors also provide a comprehensive description of predictable Type A, which is dose-related pharmacological effects and the unpredictable, bizarre, Type B hypersensitivity reactions. Tables 1 and 2 detail the common examples of clinical and genetic risks of Type B ADRs.